Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christine J. Hoffer
Observed names:
C HOFFER,
C Hoffer,
C. Hoffer,
C. J. Hoffer,
C.J. Hoffer,
CHRISTINE HOFFER,
Christine Hoffer
show all 7
Institution:
University of Washington
Observed institutions:
University of Washington,
Norwegian University of Science and Technology,
St Olav's University Hospital
OpenAlex ID:
A5111706196
Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone
2004
·
E KHARASCH
, C HOFFER
, et al.
·
Clinical Pharmacology & Therapeutics
·
254
Contribution of Itraconazole Metabolites to Inhibition of CYP3A4 In Vivo
2007
·
I E Templeton
, K E Thummel
, et al.
·
Clinical Pharmacology & Therapeutics
·
145
Circumplex Model of Affect: A Measure of Pleasure and Arousal During Virtual Reality Distraction Analgesia
2016
·
Sam R. Sharar
, Ava Alamdari
, et al.
·
Games for Health Journal
·
128
Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: Noninvasive assessment by use of pupillary miosis
2004
·
E KHARASCH
, A WALKER
, et al.
·
Clinical Pharmacology & Therapeutics
·
128
The effect of quinidine, used as a probe for the involvement of P‐glycoprotein, on the intestinal absorption and pharmacodynamics of methadone
2004
·
Evan D. Kharasch
, Christine Hoffer
, et al.
·
British Journal of Clinical Pharmacology
·
110
Influence of CYP3A5 Genotype on the Pharmacokinetics and Pharmacodynamics of the Cytochrome P4503A Probes Alfentanil and Midazolam
2007
·
E D Kharasch
, A Walker
, et al.
·
Clinical Pharmacology & Therapeutics
·
108
Mechanism of Ritonavir Changes in Methadone Pharmacokinetics and Pharmacodynamics: II. Ritonavir Effects on CYP3A and P-Glycoprotein Activities
2008
·
ED Kharasch
, PS Bedynek
, et al.
·
Clinical Pharmacology & Therapeutics
·
105
Methadone Pharmacokinetics Are Independent of Cytochrome P4503A (CYP3A) Activity and Gastrointestinal Drug Transport: Insights from Methadone Interactions with Ritonavir/Indinavir
2009
·
Evan D. Kharasch
, Christine Hoffer
, et al.
·
Anesthesiology
·
89
PDF
Disposition of nasal, intravenous, and oral methadone in healthy volunteers
2002
·
Ola Dale
, Christine Hoffer
, et al.
·
Clinical Pharmacology & Therapeutics
·
86
Quinidine as a Probe for the Role of P‐Glycoprotein in the Intestinal Absorption and Clinical Effects of Fentanyl
2004
·
Evan D. Kharasch
, Christine Hoffer
, et al.
·
The Journal of Clinical Pharmacology
·
84
Mechanism of Ritonavir Changes in Methadone Pharmacokinetics and Pharmacodynamics: I. Evidence Against CYP3A Mediation of Methadone Clearance
2008
·
ED Kharasch
, PS Bedynek
, et al.
·
Clinical Pharmacology & Therapeutics
·
80
Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity
2009
·
Evan D. Kharasch
, Alysa Walker
, et al.
·
Drug and Alcohol Dependence
·
78
Mechanism of Efavirenz Influence on Methadone Pharmacokinetics and Pharmacodynamics
2012
·
E D Kharasch
, D Whittington
, et al.
·
Clinical Pharmacology & Therapeutics
·
69
Influence of Hepatic and Intestinal Cytochrome P4503A Activity on the Acute Disposition and Effects of Oral Transmucosal Fentanyl Citrate
2004
·
Evan D. Kharasch
, Dale Whittington
, et al.
·
Anesthesiology
·
63
Influence of Age on the Pharmacokinetics and Pharmacodynamics of Oral Transmucosal Fentanyl Citrate
2004
·
Evan D. Kharasch
, Christine Hoffer
, et al.
·
Anesthesiology
·
60
PDF
Simultaneous Measurement of In Vivo P‐glycoprotein and Cytochrome P450 3A Activities
2006
·
Brian Kirby
, Evan D. Kharasch
, et al.
·
The Journal of Clinical Pharmacology
·
48
Lack of Indinavir Effects on Methadone Disposition Despite Inhibition of Hepatic and Intestinal Cytochrome P4503A (CYP3A)
2012
·
Evan D. Kharasch
, Pamela Sheffels Bedynek
, et al.
·
Anesthesiology
·
36
PDF
Sensitivity of Intravenous and Oral Alfentanil and Pupillary Miosis as Minimally Invasive and Noninvasive Probes for Hepatic and First‐Pass CYP3A Activity
2005
·
Evan D. Kharasch
, Alysa Walker
, et al.
·
The Journal of Clinical Pharmacology
·
35
Evaluation of First‐Pass Cytochrome P4503A (CYP3A) and P‐Glycoprotein Activities Using Alfentanil and Fexofenadine in Combination
2004
·
Evan D. Kharasch
, Alysa Walker
, et al.
·
The Journal of Clinical Pharmacology
·
31
Disposition and miotic effects of oral alfentanil: A potential noninvasive probe for first‐pass cytochrome P4503A activity
2003
·
Evan D. Kharasch
, Christine Hoffer
, et al.
·
Clinical Pharmacology & Therapeutics
·
31
Paradoxical Role of Cytochrome P450 3A in the Bioactivation and Clinical Effects of Levo-??-Acetylmethadol: Importance of Clinical Investigations to Validate In Vitro Drug Metabolism Studies
2005
·
Evan D Kharasch
, Dale Whittington
, et al.
·
Clinical Pharmacokinetics
·
17
KETAMINE AS A POSSIBLE MODERATOR OF HYPNOTIZABILITY: A Feasibility Study
2018
·
DAVID R. PATTERSON
, CHRISTINE HOFFER
, et al.
·
International Journal of Clinical and Experimental Hypnosis
·
8
A pilot study demonstrating effective virtual reality analgesia in the elderly
2011
·
D. Le
, S. Sharar
, et al.
·
Journal of Pain
·
3
PDF
Intrasubject Variability in Intravenous and Oral Probes for Hepatic and First-Pass CYP3A Activity
2024
·
Evan D. Kharasch
, Christine Hoffer
, et al.
·
Clinical Pharmacokinetics
·
2
Role of P‐Glycoprotein in the intestinal absorption of morphine, fentanyl and methadone
2003
·
E.D. Kharasch
, D. Whittington
, et al.
·
Clinical Pharmacology & Therapeutics
·
2
Show more works
View as search
Works count:
32
Citation count:
1,801
H-index:
20
I10-index:
21
Year
Topic
Type